BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sectorBreaking News: Trump administration impacts continue to roil the life sciences sector
Home » Topics » BioWorld

BioWorld
BioWorld RSS Feed RSS

Peanut allergy illustration

Study ties gut and saliva microbes to peanut allergy defense

March 9, 2026
By Xavier Bofill Bruna
No Comments
In an article published in Cell Host & Microbe on March 3, 2026, researchers at McMaster University in Canada and at the Hospital Universitario de La Princesa in Spain have shed some light on the impact of microbiota on peanut-driven allergy and anaphylaxis.
Read More

Appointments and advancements for March 9, 2026

March 9, 2026
New hires and promotions in the biopharma and med-tech industries, including: Cellbox, Hutchmed, Inimmune, Orexo, Salus, Tersis, Valcare, Vdyne.
Read More

BioWorld and Nasdaq stock indices

March 6, 2026
These graphs compare the performance of the biotech stocks for all of 2026 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.
Read More

Biopharma money raised: Jan. 1-March 5, 2026

March 6, 2026
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

Money raised by biopharma

March 6, 2026
Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Read More

Regulatory actions for March 6, 2026

March 6, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Airiver, Becton Dickinson, Biomerica, Drug Farm, Hansa, Hemab, Pepgen, Perimeter.
Read More

Other news to note for March 6, 2026

March 6, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bcworld, Carisma, Charles River, Daiichi Sankyo, Gaia, Grünenthal, Flo, Immunis, Imperial, Liberate, Nano-x, Novigenix, Oxipit, Sectra, Therna, Toray.
Read More

Financings for March 6, 2026

March 6, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Atavistik, Cognito, Cytodyn, Medline.
Read More

Appointments and advancements for March 6, 2026

March 6, 2026
New hires and promotions in the biopharma and med-tech industries, including: Arcutis, Avalyn, Coloplast, Invivyd, Pacbio, Sanofi, Swarm, Tango, Vera, Xylocor, Zevra.
Read More
Claire, an AI-powered imaging device

Perimeter gets FDA nod for imaging device for breast cancer surgery

March 6, 2026
By Shani Alexander
No Comments
Perimeter Medical Imaging AI Inc. secured FDA premarket approval for Claire, its AI-powered imaging device which detects difficult-to-see cancer during breast-conserving surgery. Claire combines AI with wide-field optical coherence tomography to provide surgeons with high-resolution, real-time views of excised tumor margins, to reduce the need for re-operations.
Read More
Previous 1 2 … 23 24 25 26 27 28 29 30 31 … 9050 9051 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 31, 2026.
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing